Pathogenesis and treatment of chronic hepatic encephalopathy

Digestion

Volumn 59, Issue SUPPL. 2, 1998, Pages 25-27

  Häussinger, Dieter ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Hepatic encephalopathy; Proton spectroscopy

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; FLUMAZENIL; LACTULOSE; ORNITHINE ASPARTATE;

ASTROCYTE; CELL SWELLING; CONFERENCE PAPER; DRUG EFFICACY; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERAMMONEMIA; INTRAVENOUS DRUG ADMINISTRATION; PALLIATIVE THERAPY; PATHOGENESIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0031873935     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051416     Document Type: Conference Paper

References (21)

1. Lockwood AH: Hepatic Encephalopathy. Boston, Butterworth-Heinemann, 1992.
2. Ferenci P, Püspök A, Steindl P: Current concepts in the pathogenesis of hepatic encephalopathy. Eur J Clin Invest 1992;22:573-581.
3. Norenberg MD, Neary JT, Bender AS, Dombro RS: Hepatic encephalopathy: A disorder in glial-neuronal communication; in Yu ACH, Hertz L, Norenberg MD, Sykova E, Waxman SG (eds): Progress in Brain Research. Amsterdam, Elsevier, 1992, pp 261-269.
4. Murphy S (ed): Astrocytes - Pharmacology and Function. San Diego, Academic Press, 1993.
5. Nedergaard M: Direct signalling from astrocytes to neurons in cultures of mammalian brain cells. Science 1994;263:1768-1771.
6. Häussinger D, Laubenberger J, vom Dahl S, Ernst T, Byer S, Langer M, Hennig J: Proton magnetic resonance spectroscopic studies on human brain myo-inositol in hypoosmolarity and hepatic encephalopathy. Gastroenterology 1994;107:1475-1480.
7. Laubenberger J, Häussinger D, Bayer S, Gufler H, Hennig J, Langer M: Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology 1997;112:1610-1616.
8. Lien YHH, Shapiro JL, Chan L: Effects of hypernatremia on organic brain osmoles. J Clin Invest 1990;85:1427-1435.
9. Isaacks RE, Bender AS, Kim CY, Prieto NM, Norenberg MD: Osmotic regulation of myoinositol uptake in primary astrocyte cultures. Neurochem Res 1994;19:331-338.
10. +-inositol cotransporter activity and mRNA levels in brain glial cells. Am J Physiol 1992;263:C1282-C1288.
11. Kreis R, Farrow NA, Ross BD: Diagnosis of hepatic encephalopathy by proton magnetic resonance spectroscopy. Lancet 1990;336:635-636.
12. Norenberg MD, Bender AS: Astrocyte swelling in liver failure: Role of glutamine and benzo-diazepines; in Ito U (ed): Brain Edema. IX. Vienna, Springer, 1994, pp 24-27.
13. Häussinger D: The role of cellular hydration in the regulation of cell function. Biochem J 1996; 313:697-710.
14. Schliess F, Sinnig R, Fischer R, Schmalenbach C, Häussinger D: Calcium-dependent activation of Erk-1 and Erk-2 following hypoosmotic astrocyte-swelling. Biochem J 1996;320:167-171.
15. Itzhak Y, Bender AS, Norenberg MD: Effect of hypoosmotic stress on peripheral-type benzo-diazepine receptors in cultured astrocytes. Brain Res 1994;644:221-225.
16. Norenberg MD, Itzhak Y, Bender AS, Baker L, Aguila-Mansilla N, Zhou BG, Issacks R: Ammonia and astrocyte function; in Häussinger D, Jungermann K (eds): Liver and Nervous System. Lancaster, Kluwer Press, 1998.
17. Bianchi GP, Marchesini G, Fabbri A: Vegetable versus animal protein diet in cirrhotic patients with chronic hepatic encephalopathy: A randomized cross-over comparison. J Intern Med 1993;233:385-392.
18. Strauss E, Tramote R, Silva EPS, Caly WR, Honain NZ, Maffei RA, de Sa MFG: Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy. Hepatogastroenterology 1992;39:542-545.
19. Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Görtelmeyer R, Hendricks R, Krüger B, Kulinski B, Meister H, Otto HJ, Rink C, Rösch W, Stauch S: Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: Results of a placebo-controlled double-blind trial. Hepatology 1997;25:1351-1360.
20. Plauth M, Egberts EH, Hamster W, Török M, Brand O, Fürst P, Dölle W: Long-term treatment of latent portosystemic encephalopathy with branched chain amino acids. A double-blind placebo-controlled trial. J Hepatol 1993; 17:308-314.
21. Pomier-Layrargues G, Giguere JF, Lavoie J, Perney P, Gagnon S, D'Amour M, Wells J, Butterworth RF: Flumazenil in cirrhotic patients in hepatic coma: A randomized double-blind placebo-controlled trial. Hepatology 1994;19:32-37.